KBLI 21011—Pharmaceutical Raw Materials Industry For Humans

Where 21011 sits

1. C Industry
2. 21 Pharmaceutical Preparations, Chemical Drugs, and Traditional Medicine Industry
3. 210 Pharmaceutical Preparations, Chemical Drugs, and Traditional Medicine Industry
4. 2101 Pharmaceutical Preparations and Chemical Drug Industry
5. 21011 Pharmaceutical Raw Materials Industry For Humans

What 21011 includes

• The manufacture and processing of medicinal materials, auxiliary materials for humans, which are derived from chemical materials, natural materials, animals and plants, including those derived from biological products, such as pharmaceutical ingredients, such as antisera and other blood fractions, vaccines and homeopathic preparations, active medicinal substances (antibiotics, vitamins, salicylic and o-acetylsalicylic acids and others) for pharmacological ingredients in the pharmaceutical industry, blood processing, chemical pure sugars, pharmaceutical salts, gland processing and gland extraction manufacturing.

What 21011 excludes

• The manufacture of monosodium glutamate (MSG), see subclass 10779.

21011 in other systems